Total records found: 459
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 03/09/2026 12:01 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Inside Information / Other - Business Update]
HUTCHMED ANNOUNCES LICENSING AGREEMENT WITH GSK FOR KRAS-EGFR-ANTIBODY CONJUGATE CANCER THERAPY (128KB)
Release Time: 01/09/2026 16:35 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended August 31, 2026 (67KB)
Release Time: 31/08/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Inside Information / Other - Business Update]
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS Plus TAGRISSO in Treatment-Naive Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China (95KB)
Release Time: 28/08/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces NMPA Approval for ATLED (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma (73KB)
Release Time: 18/08/2026 17:04 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Change in a Director's or Supervisor's Biographical Details]
ANNOUNCEMENT PURSUANT TO RULES 13.51B(2) AND 13.51(2)(l) OF THE LISTING RULES (82KB)
Release Time: 17/08/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Inside Information / Other - Business Update]
HUTCHMED Announces ORPATHYS Plus TAGRISSO Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO (103KB)
Release Time: 14/08/2026 16:32 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Circulars - [Other]
Notification letter to non-registered shareholders and reply form: Notice of Publication of the 2026 Interim Report (946KB)
Release Time: 14/08/2026 16:31 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Circulars - [Other]
Notification letter to registered shareholders and reply form: Notice of Publication of the 2026 Interim Report (1016KB)
Release Time: 14/08/2026 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2026 Interim Report (6MB)
Release Time: 03/08/2026 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended July 31, 2026 (68KB)
Release Time: 30/07/2026 19:01 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Interim Results]
HUTCHMED Reports 2026 Interim Results (1MB)
Release Time: 02/07/2026 16:40 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended June 30, 2026 (67KB)
Release Time: 02/07/2026 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces NMPA Approval for ORPATHYS for the treatment of Gastric Cancer Patients with MET Amplification (92KB)
Release Time: 30/06/2026 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING AND ANNOUNCEMENT OF 2026 INTERIM RESULTS (44KB)
Release Time: 29/06/2026 16:37 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Blocklisting Six Monthly Return (408KB)
Release Time: 25/06/2026 08:02 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026 (73KB)
Release Time: 12/06/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress (81KB)
Release Time: 05/06/2026 16:34 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Block Admission Application (454KB)
Release Time: 01/06/2026 17:35 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended May 31, 2026 (67KB)
Release Time: 22/05/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting (99KB)
Release Time: 21/05/2026 18:16 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting (87KB)
Release Time: 21/05/2026 18:04 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE (Fruquintinib) in Combination with TYVYT (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma (87KB)
Release Time: 13/05/2026 16:38 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (249KB)
Release Time: 12/05/2026 19:47 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Results of AGM]
Annual General Meeting held on May 12, 2026 - Poll Results (160KB)
Release Time: 04/05/2026 16:41 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended April 30, 2026 (68KB)
Release Time: 30/04/2026 16:42 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Total Voting Rights (252KB)
Release Time: 29/04/2026 18:04 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (79KB)
Release Time: 09/04/2026 16:44 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Documents on Display
2026 Share Option Scheme (323KB)
Release Time: 09/04/2026 16:37 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Circulars - [Other]
Notification letter to non-registered shareholders and reply form: (1) Annual General Meeting ("AGM"); and (2) Notice of publication of the 2025 Annual Report, Circular, Notice of AGM and Form of Proxy in relation to the AGM and 2025 Sustainability Report (858KB)
Release Time: 09/04/2026 16:36 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Circulars - [Other]
Notification letter to registered holders and reply form: (1) Annual General Meeting ("AGM"); and (2) Notice of publication of the 2025 Annual Report, Circular, Notice of AGM and Form of Proxy in relation to the AGM and 2025 Sustainability Report (921KB)
Release Time: 09/04/2026 16:35 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
2025 Annual Report and Notice of Annual General Meeting (354KB)
Release Time: 09/04/2026 16:34 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Proxy Forms
Form of Proxy for Use at the Annual General Meeting (96KB)
Release Time: 09/04/2026 16:33 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Notice of AGM / Re-election or Appointment of Director subject to Shareholders' Approval /...
More
Announcements and Notices - [Notice of AGM / Re-election or Appointment of Director subject to Shareholders' Approval / Closure of Books or Change of Book Closure Period / Share Scheme]
]
Notice of Annual General Meeting (171KB)
Release Time: 09/04/2026 16:32 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory...
More
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares / Share Scheme]
]
Notice of Annual General Meeting; Proposals for Re-election of Directors, General Mandates to Issue New Shares and Repurchase Shares and Adoption of the 2026 Share Option Scheme (207KB)
Release Time: 09/04/2026 16:31 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]
2025 Sustainability Report (7MB)
Release Time: 09/04/2026 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Financial Statements/ESG Information - [Annual Report]
2025 Annual Report (13MB)
Release Time: 09/04/2026 08:01 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026 (79KB)
Release Time: 01/04/2026 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended March 31, 2026 (67KB)
Release Time: 23/03/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China (74KB)
Release Time: 16/03/2026 16:31 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Vesting of awards under the Long Term Incentive Plan (262KB)
Release Time: 11/03/2026 16:34 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Vesting of awards under the Long Term Incentive Plan (273KB)
Release Time: 09/03/2026 17:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK in China (69KB)
Release Time: 06/03/2026 16:36 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of...
More
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Nomination Committee Member]
]
Intended retirement of Independent Non-executive Director and changes of composition of board committees (146KB)
Release Time: 05/03/2026 20:39 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Trading Update]
Publication of Form 20-F (4MB)
Release Time: 05/03/2026 19:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]
HUTCHMED Reports 2025 Full Year Results and Business Updates (1MB)
Release Time: 04/03/2026 16:37 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors (71KB)
Release Time: 02/03/2026 17:53 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended February 28, 2026 (67KB)
Release Time: 06/02/2026 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING AND ANNOUNCEMENT OF 2025 FINAL RESULTS (39KB)
Release Time: 02/02/2026 17:07 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended January 31, 2026 (67KB)
Release Time: 14/01/2026 12:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet (128KB)
Release Time: 07/01/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China (77KB)
Release Time: 05/01/2026 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naive Pancreatic Ductal Adenocarcinoma (75KB)
Release Time: 02/01/2026 16:56 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended December 31, 2025 (65KB)
Release Time: 31/12/2025 15:01 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Total Voting Rights (335KB)
Release Time: 30/12/2025 18:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification (73KB)
Release Time: 29/12/2025 16:37 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Blocklisting Six Monthly Return (402KB)
Release Time: 29/12/2025 16:33 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma (65KB)
Release Time: 17/12/2025 08:01 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors (72KB)
Release Time: 08/12/2025 08:01 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China (1MB)
Release Time: 01/12/2025 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended November 30, 2025 (65KB)
Release Time: 28/11/2025 16:32 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Total Voting Rights (333KB)
Release Time: 27/11/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting (95KB)
Release Time: 05/11/2025 08:02 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS and TAGRISSO Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO (119KB)
Release Time: 03/11/2025 16:37 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended October 31, 2025 (64KB)
Release Time: 03/11/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event (110KB)
Release Time: 23/10/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (250KB)
Release Time: 21/10/2025 16:41 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Vesting of awards under the Long Term Incentive Plan (408KB)
Release Time: 15/10/2025 16:35 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (247KB)
Release Time: 14/10/2025 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee (84KB)
Release Time: 13/10/2025 12:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress (78KB)
Release Time: 02/10/2025 16:50 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended September 30, 2025 (65KB)
Release Time: 02/10/2025 08:02 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2025 (89KB)
Release Time: 30/09/2025 16:34 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Total Voting Rights (335KB)
Release Time: 12/09/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025 (59KB)
Release Time: 05/09/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025 (90KB)
Release Time: 01/09/2025 16:43 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended August 31, 2025 (64KB)
Release Time: 25/08/2025 16:51 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (246KB)
Release Time: 25/08/2025 08:20 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change in Chief...
More
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change in Chief Executive]
]
HUTCHMED Announces Appointment of Acting Chief Executive Officer (50KB)
Release Time: 22/08/2025 16:37 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Circulars - [Other]
Notification letter to non-registered shareholders and reply form: Notice of Publication of the 2025 Interim Report (871KB)
Release Time: 22/08/2025 16:35 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Circulars - [Other]
Notification letter to registered shareholders and reply form: Notice of Publication of the 2025 Interim Report (927KB)
Release Time: 22/08/2025 16:34 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2025 Interim Report (5MB)
Release Time: 20/08/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS and TAGRISSO Combination as a First-Line Therapy for Certain Lung Cancer Patients in China (118KB)
Release Time: 07/08/2025 19:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Interim Results]
HUTCHMED Reports 2025 Interim Results (1MB)
Release Time: 01/08/2025 16:30 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended July 31, 2025 (64KB)
Release Time: 03/07/2025 16:31 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING AND ANNOUNCEMENT OF 2025 INTERIM RESULTS (44KB)
Release Time: 02/07/2025 17:03 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Update on Joint Corporate Brokers in London (316KB)
Release Time: 02/07/2025 16:37 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended June 30, 2025 (65KB)
Release Time: 30/06/2025 16:35 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Blocklisting Six Monthly Return (378KB)
Release Time: 30/06/2025 16:34 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Total Voting Rights (349KB)
Release Time: 30/06/2025 16:32 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Inside Information / Other - Business Update]
HUTCHMED Announces China Approval for ORPATHYS in Combination with TAGRISSO for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy (125KB)
Release Time: 20/06/2025 16:41 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Terms of Reference of the Nomination Committee]
Nomination Committee - Terms of Reference (115KB)
Release Time: 20/06/2025 16:39 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Terms of Reference of the Audit Committee]
Audit Committee - Terms of Reference (198KB)
Release Time: 10/06/2025 18:07 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Share Scheme]
Grant of Share Options under Share Option Scheme and Awards under Long Term Incentive Plan (91KB)
Release Time: 05/06/2025 07:45 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma (116KB)
Release Time: 02/06/2025 16:52 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended May 31, 2025 (65KB)
Release Time: 02/06/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting (78KB)
Release Time: 30/05/2025 16:35 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Other]
Total Voting Rights (350KB)
Release Time: 23/05/2025 08:00 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Overseas Regulatory Announcement - Business Update]
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting (166KB)
Release Time: 14/05/2025 16:38 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (245KB)
Release Time: 13/05/2025 18:46 Stock Code: 00013 Stock Short Name: HUTCHMED Document:
Announcements and Notices - [Results of AGM]
Annual General Meeting held on May 13, 2025 - Poll Results (196KB)
Showing 100 of 459 records
Showing 100 of 459 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.